483 Corporativo Serysi, S. De R.L. De C.V. Aug 2019

483 Corporativo Serysi, S. De R.L. De C.V. Aug 2019

$119 - Not in Stock

FDA investigators audited the Corporativo Serysi, S. De R.L. De C.V. - Zapopan, Mexico facility and issued inspectional observations (via FDA 483) on 16 Aug 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Aug 2019
  • Location: Zapopan, Mexico
  • FEI: 3012097599

Pre-Order Not Available